Chelsey Carlson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Juniper Ave, Slayton, MN 56172 Phone: 507-873-2075 Fax: 507-873-2076 |
Natalie Rae Brown Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2622 Broadway Ave, Slayton, MN 56172 Phone: 507-836-6702 Fax: 507-836-8753 |
Cara Rae Mahon, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2042 Juniper Ave, Slayton, MN 56172 Phone: 507-836-1291 |
Larry Dean Hafner Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2622 Broadway Ave, Slayton, MN 56172 Phone: 507-836-6159 Fax: 507-836-8753 |
Kayla Jean Royer, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Juniper Ave, Slayton, MN 56172 Phone: 507-873-2075 |
Maci Kruisselbrink Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2622 Broadway Ave, Slayton, MN 56172 Phone: 507-836-6702 |
News Archive
The motto "no guts, no glory" may need rewriting if Rice University synthetic biologist Jeff Tabor succeeds in his quest to help the Navy create an edible probiotic bacterium that can help protect sailors and marines from obesity and depression.
Shire plc, the global specialty biopharmaceutical company, today announced that data from one of three Phase III clinical trials for velaglucerase alfa, the company's enzyme replacement therapy (ERT) in development for the treatment of Type 1 Gaucher disease, will be presented at the Lysosomal Disease Network (LDN) World Symposium, February 10-12, 2010 in Miami, Florida.
Fake medicines increasingly put patients and the general public at risk across the world. In response to this challenge, ten partners who represent healthcare professionals, disease-specific organizations, product-development partnerships, foundations, international financing institutions, as well as the research-based pharmaceutical industry have joined forces to raise awareness about the dangers of fake medicines.
CANCER RESEARCH UK scientists have revealed that a 'detox' protein which mops up harmful 'reactive oxygen' in cells could also trigger pancreatic and lung cancer development, according to a study published in Nature, today.
Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company will be attending the Nuclear Science Symposium and Medical Imaging Conference in Seoul Korea from October 27 through November 2, 2013 in Seoul, Korea.
› Verified 9 days ago